What is the recommended evaluation and management for a patient with a suspected subdural hematoma?

Subdural Hematoma: Evaluation and Management

For suspected subdural hematoma, obtain immediate non-contrast head CT as the primary diagnostic tool, followed by neurosurgical consultation for symptomatic patients or those with significant mass effect (>1 cm thickness), with burr-hole craniostomy plus subdural drainage as the standard surgical approach.

Initial Diagnostic Evaluation

Imaging Strategy

• Non-contrast head CT is the first-line imaging modality for all patients with suspected subdural hematoma 1
• CT provides rapid identification of hemorrhage location, size, and mass effect
• MRI can be used as an alternative in subacute/chronic cases with unexplained cognitive or neurologic deficits, particularly when CT findings are equivocal 1
• Sagittal and coronal reformats best demonstrate the characteristic crescentic fluid layering in the subdural space 2

Clinical Assessment Focus

Look specifically for:

• Glasgow Coma Scale (GCS) score to stratify severity
• Focal neurologic deficits (weakness, sensory changes)
• Cognitive changes or confusion (especially in elderly)
• Gait disturbances
• Progressive somnolence
• History of anticoagulation/antiplatelet use
• Recent head trauma (may be minor or remote, particularly in chronic subdural hematoma)

Management Algorithm

Acute Subdural Hematoma (Symptomatic or Severe)

Immediate neurosurgical consultation is mandatory for:

• Any symptomatic patient with neurologic deficit
• Hematoma with significant mass effect
• GCS ≤12 (moderate to severe head injury) 1

Chronic Subdural Hematoma

Surgical Indications

Operate when:

• Maximum fluid collection thickness >1 cm 2
• Patient is symptomatic (confusion, focal deficits, gait disturbance)
• Evidence of mass effect on imaging 3

Surgical Technique

Burr-hole craniostomy with subdural drainage is the standard approach 3, 2:

• Use warm (37°C) Ringer's lactate for irrigation 3
• Place postoperative subdural drain (reduces recurrence) 3, 2
• For large bilateral hematomas, evacuate both sides 3

Emerging Endovascular Option

Middle meningeal artery embolization (MMAE) is now evidence-based 4:

• MMAE plus surgery reduces 90-day recurrence to 4.1% vs 11.3% with surgery alone 4
• Can be used as adjunctive therapy with surgery or as standalone treatment in high-risk surgical patients
• Recent trials (EMBOLISE, STEM, MAGIC-MT, MEMBRANE) demonstrate safety and efficacy 4
• Consider for patients at high recurrence risk or those who are poor surgical candidates

Conservative Management

Reserve for:

• Asymptomatic patients with small hematomas (<1 cm)
• Minimal or no mass effect
• Stable neurologic examination

Close monitoring required with serial neurologic exams and repeat imaging if clinical deterioration occurs.

Anticoagulation Management

Initial Reversal

• Reverse anticoagulation immediately upon diagnosis in symptomatic patients
• For warfarin: use vitamin K plus prothrombin complex concentrate
• For direct oral anticoagulants (DOACs): use specific reversal agents when available

Special Considerations for Mild Head Injury on Anticoagulation

For patients on anticoagulation with mild head injury (GCS 13-15) and negative initial CT 5:

• Delayed intracranial hemorrhage is rare (0.6% for warfarin, 0% for clopidogrel in one study)
• Consider 24-hour observation with repeat CT at 20-24 hours, particularly for warfarin patients
• The evidence shows conflicting approaches: some data suggest observation may not be necessary if initial CT negative, while other studies support 24-hour observation with repeat imaging

Restarting Anticoagulation

This remains an area without clear consensus 3. Balance:

• Thrombotic risk (stroke, MI, PE)
• Hemorrhage recurrence risk (10-20% overall) 2
• Consider patient's underlying indication (mechanical valve vs atrial fibrillation)
• Typically delay 1-4 weeks post-surgery, individualized based on hematoma resolution and thrombotic risk

Postoperative Management

Standard Care

• Early mobilization (consensus recommendation) 3
• Sequential compression devices to prevent venous thromboembolism 2
• Monitor for neurologic deterioration

Follow-up Imaging

• Routine postoperative CT in asymptomatic patients lacks consensus 3
• Obtain repeat CT for:
  • New or progressive neurologic deficits 1
  • Clinical deterioration
  • Unchanged exam with known hemorrhage on initial imaging 1

Recurrence Monitoring

• Recurrence affects 10-20% of patients 2
• Higher risk with:
  • Bilateral hematomas
  • Continued anticoagulation
  • Inadequate drainage
• Close outpatient follow-up essential for 3-6 months

Critical Pitfalls to Avoid

1. Delaying CT in elderly patients with subtle symptoms - confusion or gait changes may be the only manifestation
2. Assuming minor trauma rules out significant hematoma - chronic subdural can develop from trivial or unrecognized injury
3. Premature anticoagulation restart - balance carefully against thrombotic risk
4. Discharging anticoagulated patients with negative initial CT without observation - delayed hemorrhage can occur, particularly with warfarin
5. Missing bilateral hematomas - review entire calvarium on imaging
6. Inadequate drainage duration - keep drains at least 24 hours to reduce recurrence